sulfinpyrazone has been researched along with Extravascular Hemolysis in 3 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Häussinger, G | 1 |
| Pfennigs, H | 1 |
| Chelapurath, A | 1 |
| Reul, H | 1 |
| Essers, U | 1 |
| Errington, M | 1 |
| Bloomfield, P | 1 |
| Jobin, F | 1 |
| Gagnon, FT | 1 |
3 other studies available for sulfinpyrazone and Extravascular Hemolysis
| Article | Year |
|---|---|
[Influence of platelet aggregation inhibitors on platelet damage at prosthetic heart valves in-vitro (author's transl)].
Topics: Aspirin; Blood Platelets; Dipyridamole; Heart Valve Prosthesis; Hemolysis; Humans; Lysine; Platelet | 1981 |
Does sulphinpyrazone reduce haemolysis from prosthetic heart valves?
Topics: Aged; Anemia, Hemolytic; Bioprosthesis; Female; Heart Valve Prosthesis; Hemolysis; Humans; Male; Mid | 1992 |
Platelet reactions and immune processes. IV. The inhibition of complement by pyrazole compounds and other inhibitors of platelet reactions.
Topics: Animals; Blood Coagulation; Blood Platelets; Chloroquine; Complement Inactivator Proteins; Erythrocy | 1970 |